应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PMN ProMIS Neurosciences Inc
交易中 04-10 14:33:43 EDT
0.5403
-0.0339
-5.90%
最高
0.6700
最低
0.5403
成交量
2.50万
今开
0.5700
昨收
0.5742
日振幅
22.59%
总市值
1,766万
流通市值
943.47万
总股本
3,269万
成交额
1.54万
换手率
0.14%
流通股本
1,746万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Promis Neurosciences Inc.盘中异动 早盘急速上涨6.55%报0.830美元
市场透视 · 03-05
Promis Neurosciences Inc.盘中异动 早盘急速上涨6.55%报0.830美元
Promis Neurosciences Inc.盘中异动 快速跳水12.56%
市场透视 · 03-03
Promis Neurosciences Inc.盘中异动 快速跳水12.56%
Promis Neurosciences Inc.盘中异动 早盘股价大跌6.49%报0.720美元
市场透视 · 02-27
Promis Neurosciences Inc.盘中异动 早盘股价大跌6.49%报0.720美元
Promis Neurosciences Inc.盘中异动 股价大跌5.41%
市场透视 · 02-19
Promis Neurosciences Inc.盘中异动 股价大跌5.41%
Promis Neurosciences Inc.盘中异动 早盘股价大涨9.63%报1.000美元
市场透视 · 02-13
Promis Neurosciences Inc.盘中异动 早盘股价大涨9.63%报1.000美元
Promis Neurosciences Inc.盘中异动 大幅上涨5.91%报0.985美元
市场透视 · 02-06
Promis Neurosciences Inc.盘中异动 大幅上涨5.91%报0.985美元
Promis Neurosciences Inc.盘中异动 早盘股价大涨5.12%报0.940美元
市场透视 · 01-30
Promis Neurosciences Inc.盘中异动 早盘股价大涨5.12%报0.940美元
Promis Neurosciences Inc.盘中异动 股价大涨10.75%
市场透视 · 01-27
Promis Neurosciences Inc.盘中异动 股价大涨10.75%
Promis Neurosciences Inc.盘中异动 股价大涨5.85%
市场透视 · 01-23
Promis Neurosciences Inc.盘中异动 股价大涨5.85%
Promis Neurosciences Inc.盘中异动 快速下跌5.97%
市场透视 · 01-22
Promis Neurosciences Inc.盘中异动 快速下跌5.97%
Promis Neurosciences Inc.盘中异动 早盘大幅拉升8.98%
市场透视 · 01-21
Promis Neurosciences Inc.盘中异动 早盘大幅拉升8.98%
Promis Neurosciences Inc.盘中异动 股价大涨5.10%
市场透视 · 01-16
Promis Neurosciences Inc.盘中异动 股价大涨5.10%
Promis Neurosciences Inc.盘中异动 早盘股价大跌5.50%
市场透视 · 01-15
Promis Neurosciences Inc.盘中异动 早盘股价大跌5.50%
Promis Neurosciences Inc.盘中异动 早盘急速下挫5.00%报0.950美元
市场透视 · 01-14
Promis Neurosciences Inc.盘中异动 早盘急速下挫5.00%报0.950美元
Promis Neurosciences Inc.盘中异动 股价大跌5.83%
市场透视 · 01-13
Promis Neurosciences Inc.盘中异动 股价大跌5.83%
Promis Neurosciences Inc.盘中异动 急速上涨5.20%
市场透视 · 01-06
Promis Neurosciences Inc.盘中异动 急速上涨5.20%
Promis Neurosciences Inc.盘中异动 下午盘股价大涨5.39%报0.949美元
市场透视 · 2024-12-31
Promis Neurosciences Inc.盘中异动 下午盘股价大涨5.39%报0.949美元
Promis Neurosciences Inc.盘中异动 快速上涨5.20%
市场透视 · 2024-12-20
Promis Neurosciences Inc.盘中异动 快速上涨5.20%
Promis Neurosciences Inc.盘中异动 早盘急速拉升5.32%报0.930美元
市场透视 · 2024-12-19
Promis Neurosciences Inc.盘中异动 早盘急速拉升5.32%报0.930美元
加载更多
公司概况
公司名称:
ProMIS Neurosciences Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
ProMIS Neurosciences Inc.根据加拿大商业公司法于2004年1月23日成立,位于安大略省多伦多市央街1920号。该公司正在应用其专利技术平台,在神经退行性疾病和其他错误折叠的蛋白质疾病(包括阿尔茨海默病多系统萎缩和肌萎缩性侧索硬化症)中构建抗体疗法、治疗性疫苗和其他基于抗体的疗法组合。该公司还计划研究其他突触核蛋白病,包括帕金森病和路易体痴呆、额颞叶变性、进行性核上性麻痹、皮质基底节变性和精神分裂症。这些疾病有一个共同的生物学原因——错误折叠的蛋白质,否则会发挥正常功能,变得有毒并杀死神经元,从而导致疾病。ProMIS的技术平台是通过计算能力、计算机发现和人工智能实现药物发现进步的一个例子。
发行价格:
--
{"stockData":{"symbol":"PMN","market":"US","secType":"STK","nameCN":"ProMIS Neurosciences Inc","latestPrice":0.5403,"timestamp":1744309793874,"preClose":0.5742,"halted":0,"volume":25005,"delay":0,"floatShares":17461973,"shares":32689190,"eps":0.107209,"marketStatus":"交易中","change":-0.0339,"latestTime":"04-10 14:33:43 EDT","open":0.57,"high":0.67,"low":0.5403,"amount":15366.337653,"amplitude":0.225879,"askPrice":0.565,"askSize":300,"bidPrice":0.54,"bidSize":200,"shortable":0,"etf":0,"ttmEps":0.107209,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1744315200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.5742,"volumeRatio":0.68159},"requestUrl":"/m/hq/s/PMN","defaultTab":"news","newsList":[{"id":"2517574941","title":"Promis Neurosciences Inc.盘中异动 早盘急速上涨6.55%报0.830美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517574941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517574941?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:57","pubTimestamp":1741190237,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时57分,Promis Neurosciences Inc.股票出现波动,股价大幅上涨6.55%。截至发稿,该股报0.830美元/股,成交量7251股,换手率0.02%,振幅3.90%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为1.50%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235717963af135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235717963af135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXF","PMN","ARFXD"],"gpt_icon":0},{"id":"2516598456","title":"Promis Neurosciences Inc.盘中异动 快速跳水12.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516598456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516598456?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:25","pubTimestamp":1741022716,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时25分,Promis Neurosciences Inc.股票出现异动,股价急速下跌12.56%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.35%。其相关个股中,Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Alto Neuroscience, Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为4182.16%、177.33%、156.20%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.,振幅分别为206.20%、119.50%、70.53%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304012516abe667ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304012516abe667ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","BK4139","ARFXF","ARFXD"],"gpt_icon":0},{"id":"2514238270","title":"Promis Neurosciences Inc.盘中异动 早盘股价大跌6.49%报0.720美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514238270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514238270?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:04","pubTimestamp":1740672240,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时04分,Promis Neurosciences Inc.股票出现波动,股价急速下跌6.49%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000401abdf857d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000401abdf857d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","BK4139","ARFXF","ARFXD"],"gpt_icon":0},{"id":"2512847534","title":"Promis Neurosciences Inc.盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512847534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512847534?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:36","pubTimestamp":1739983009,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时36分,Promis Neurosciences Inc.股票出现异动,股价急速下跌5.41%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.46%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003649a24c12fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003649a24c12fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","BK4139","PMN"],"gpt_icon":0},{"id":"2511452508","title":"Promis Neurosciences Inc.盘中异动 早盘股价大涨9.63%报1.000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511452508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511452508?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457063,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分,Promis Neurosciences Inc.股票出现异动,股价大幅拉升9.63%。截至发稿,该股报1.000美元/股,成交量2363股,换手率0.01%,振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体跌幅为0.01%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223103abcdb1d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223103abcdb1d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXF","PMN","ARFXD"],"gpt_icon":0},{"id":"2509220600","title":"Promis Neurosciences Inc.盘中异动 大幅上涨5.91%报0.985美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509220600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509220600?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:37","pubTimestamp":1738859853,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时37分,Promis Neurosciences Inc.股票出现异动,股价急速上涨5.91%。截至发稿,该股报0.985美元/股,成交量6992股,换手率0.02%,振幅3.23%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.08%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003733987ca217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003733987ca217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXD","PMN","ARFXF"],"gpt_icon":0},{"id":"2507624281","title":"Promis Neurosciences Inc.盘中异动 早盘股价大涨5.12%报0.940美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507624281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507624281?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:49","pubTimestamp":1738248549,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时49分,Promis Neurosciences Inc.股票出现波动,股价急速拉升5.12%。截至发稿,该股报0.940美元/股,成交量2028股,换手率0.01%,振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.28%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302249099876b3dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302249099876b3dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","BK4139","ARFXF","PMN"],"gpt_icon":0},{"id":"2506305280","title":"Promis Neurosciences Inc.盘中异动 股价大涨10.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506305280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506305280?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:50","pubTimestamp":1737989421,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时50分,Promis Neurosciences Inc.股票出现波动,股价急速上涨10.75%。截至发稿,该股报0.990美元/股,成交量2320股,换手率0.01%,振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为1.09%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225022a2316ef3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225022a2316ef3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","PMN","BK4139","ARFXF"],"gpt_icon":0},{"id":"2505049965","title":"Promis Neurosciences Inc.盘中异动 股价大涨5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505049965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505049965?lang=zh_cn&edition=full","pubTime":"2025-01-24 01:24","pubTimestamp":1737653081,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日01时24分,Promis Neurosciences Inc.股票出现波动,股价大幅拉升5.85%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.77%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124012441a22d2d07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124012441a22d2d07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","PMN","ARFXD","BK4139"],"gpt_icon":0},{"id":"2505577065","title":"Promis Neurosciences Inc.盘中异动 快速下跌5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505577065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505577065?lang=zh_cn&edition=full","pubTime":"2025-01-23 03:30","pubTimestamp":1737574235,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日03时30分,Promis Neurosciences Inc.股票出现波动,股价大幅跳水5.97%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体跌幅为0.18%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123033035960d2e12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123033035960d2e12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","ARFXF","BK4139","ARFXD"],"gpt_icon":0},{"id":"2505542272","title":"Promis Neurosciences Inc.盘中异动 早盘大幅拉升8.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505542272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505542272?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:33","pubTimestamp":1737469987,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时33分,Promis Neurosciences Inc.股票出现波动,股价急速拉升8.98%。截至发稿,该股报0.970美元/股,成交量5797股,换手率0.02%,振幅6.18%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.89%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223307960bb946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223307960bb946&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXD","PMN","ARFXF"],"gpt_icon":0},{"id":"2503915753","title":"Promis Neurosciences Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503915753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503915753?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:01","pubTimestamp":1737039711,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时01分,Promis Neurosciences Inc.股票出现异动,股价快速上涨5.10%。截至发稿,该股报0.960美元/股,成交量1958股,换手率0.01%,振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体跌幅为0.91%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116230151abad56fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116230151abad56fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","BK4139","PMN"],"gpt_icon":0},{"id":"2503110640","title":"Promis Neurosciences Inc.盘中异动 早盘股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503110640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503110640?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:53","pubTimestamp":1736952783,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时53分,Promis Neurosciences Inc.股票出现波动,股价快速下挫5.50%。截至发稿,该股报0.890美元/股,成交量1.3754万股,换手率0.04%,振幅1.43%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.88%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115225304ababf80e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115225304ababf80e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","PMN","ARFXD","BK4139"],"gpt_icon":0},{"id":"2503574540","title":"Promis Neurosciences Inc.盘中异动 早盘急速下挫5.00%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503574540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503574540?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:38","pubTimestamp":1736865480,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时38分,Promis Neurosciences Inc.股票出现异动,股价急速下跌5.00%。截至发稿,该股报0.950美元/股,成交量551股,换手率0.00%,振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体跌幅为0.19%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011422380096038152&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011422380096038152&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","BK4139","ARFXF","PMN"],"gpt_icon":0},{"id":"2503758105","title":"Promis Neurosciences Inc.盘中异动 股价大跌5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503758105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503758105?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:34","pubTimestamp":1736782484,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日23时34分,Promis Neurosciences Inc.股票出现异动,股价大幅下挫5.83%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体跌幅为1.20%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011323344596025f59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011323344596025f59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","PMN","BK4139"],"gpt_icon":0},{"id":"2501560542","title":"Promis Neurosciences Inc.盘中异动 急速上涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501560542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501560542?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:38","pubTimestamp":1736174302,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时38分,Promis Neurosciences Inc.股票出现异动,股价大幅上涨5.20%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体跌幅为0.13%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010622382295fa7423&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010622382295fa7423&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","BK4139","ARFXF","ARFXD"],"gpt_icon":0},{"id":"2500417246","title":"Promis Neurosciences Inc.盘中异动 下午盘股价大涨5.39%报0.949美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500417246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500417246?lang=zh_cn&edition=full","pubTime":"2025-01-01 03:31","pubTimestamp":1735673510,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日03时31分,Promis Neurosciences Inc.股票出现异动,股价快速拉升5.39%。截至发稿,该股报0.949美元/股,成交量3.2499万股,换手率0.10%,振幅4.99%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.26%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501010331519856cd54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501010331519856cd54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXF","PMN","ARFXD"],"gpt_icon":0},{"id":"2492440158","title":"Promis Neurosciences Inc.盘中异动 快速上涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492440158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492440158?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:03","pubTimestamp":1734707000,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日23时03分,Promis Neurosciences Inc.股票出现异动,股价急速上涨5.20%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体跌幅为0.30%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122023032095ea9d22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122023032095ea9d22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","BK4139","PMN","ARFXD"],"gpt_icon":0},{"id":"2492712361","title":"Promis Neurosciences Inc.盘中异动 早盘急速拉升5.32%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492712361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492712361?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:36","pubTimestamp":1734618964,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时36分,Promis Neurosciences Inc.股票出现异动,股价急速拉升5.32%。截至发稿,该股报0.930美元/股,成交量7610股,换手率0.02%,振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体跌幅为2.44%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223613a1fb5a1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223613a1fb5a1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","PMN","ARFXD","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.promisneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.2034},{"period":"1month","weight":-0.274},{"period":"3month","weight":-0.4448},{"period":"6month","weight":-0.4448},{"period":"1year","weight":-0.7726},{"period":"ytd","weight":-0.4025}],"compareEarnings":[{"period":"1week","weight":-0.0282},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0693},{"period":"6month","weight":-0.0534},{"period":"1year","weight":0.0564},{"period":"ytd","weight":-0.0639}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ProMIS Neurosciences Inc.根据加拿大商业公司法于2004年1月23日成立,位于安大略省多伦多市央街1920号。该公司正在应用其专利技术平台,在神经退行性疾病和其他错误折叠的蛋白质疾病(包括阿尔茨海默病多系统萎缩和肌萎缩性侧索硬化症)中构建抗体疗法、治疗性疫苗和其他基于抗体的疗法组合。该公司还计划研究其他突触核蛋白病,包括帕金森病和路易体痴呆、额颞叶变性、进行性核上性麻痹、皮质基底节变性和精神分裂症。这些疾病有一个共同的生物学原因——错误折叠的蛋白质,否则会发挥正常功能,变得有毒并杀死神经元,从而导致疾病。ProMIS的技术平台是通过计算能力、计算机发现和人工智能实现药物发现进步的一个例子。","exchange":"NASDAQ","name":"ProMIS Neurosciences Inc","nameEN":"ProMIS Neurosciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.2","shortVersion":"4.32.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ProMIS Neurosciences Inc(PMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ProMIS Neurosciences Inc,PMN,ProMIS Neurosciences Inc股票,ProMIS Neurosciences Inc股票老虎,ProMIS Neurosciences Inc股票老虎国际,ProMIS Neurosciences Inc行情,ProMIS Neurosciences Inc股票行情,ProMIS Neurosciences Inc股价,ProMIS Neurosciences Inc股市,ProMIS Neurosciences Inc股票价格,ProMIS Neurosciences Inc股票交易,ProMIS Neurosciences Inc股票购买,ProMIS Neurosciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ProMIS Neurosciences Inc(PMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}